• 1
    Akpala OC, Okonkwo PO, Nwagbo D, Nwakoby B (1993a) Comparison of three strategies for mass distribution of ivermectin in Eastern Nigeria. Annals of Tropical Medicine and Parasitolgy 87, 399402.
  • 2
    Akpala OC, Okonkwo PO, Nwagbo D (1993b) Mobilization for mass distribution of ivermectin in Eastern Nigeria. Journal of Health Policy and Planning 8, 7881.
  • 3
    Amazigo UO (1994) Detrimental effects of onchocerciasis on marriage age and breast feeding. Tropical and Geographical Medicine 46, 322325.
  • 4
    De Ferranti D (1985) Paying for health services in developing countries: a call for realism. World Health Forum 6, 99105.
  • 5
    Golan EH, Shechter M (1993). Contingent valuation of supplemental health care in Israel. Decision Making 13 (3023), 10.
  • 6
    Gordon J, Mace JK, Cadot E, Ogil C, Godin C, Boussinessq M (1996) Ivermectin-based control of onchocerciasis in Northern Cameroon: Individual factors influencing participation in community treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 218222.
  • 7
    Jancloes M, Seck B, Van De Velden , Ndiaye B (1985) Financing urban primary health services – balancing community and government financial responsibilities. Pikine, Senegal 1975–81. Tropical Doctor 15, 95104.
  • 8
    Johannesson M (1993) The contingent valuation method – Appraising the appraisers. Health Economics 2, 357359.
  • Mitchell RC & Carson RT (1989)
    Using Surveys to Value Public Goods: The Contingent Valuation Method. Resources for the future Inc., Washington DC.
  • National Onchocerciasis Control Programme (1993)
    National plan for the control of onchocerciasis (River blindness) in Nigeria. Federal Ministry of Health and Human Services, Lagos, pp. 3–20.
  • National Onchocerciasis Control Programme (1994)
    Progress report. Federal Ministry of Health and Human Services, Lagos, pp. 1–12.
  • O'Brien B & Viramontes JL (1993)
    Willingness to pay: A valid and reliable measure of health state preference? McMaster University Center for Health Economics and Policy analysis working paper, pp. 93–97.
  • 13
    Ojanuga DN (1985) Construction of Mujedawa dispensary in Kaduna state, Nigeria through self-help. World Health Forum 6, 108109.
  • 14
    Okonkwo PO, Akpa A, Ihekwaba A et al, (1991) Studies on onchocerciasis in forest-savannah mosaic areas of Nigeria.1. Investigations in Gbaragu, Oji River. Annals of Tropical Medicine and Parasitology 85, 617623.
  • 15
    Onwujekwe OE (1996) Modeling of costs for local ivermectin distribution, Onchocerciasis unit, University of Nigeria, Enugu.
  • 16
    Plaiser AP, Van Oortmarssen GJ, Habbema JDF, Remme J, Alley ES (1990) Onchosim: a model and computer simulation program for the transmission and control of onchocerciasis. Computer Methods and Programs in Biomedicine 31, 4356.
  • Ransome-kuti O (1992)
    Strengthening Primary Health Care at Local Level. The Nigerian experience. Academy Press, Lagos, pp. 21–41.
  • 18
    Remme J, De Sole G, Van Oortmarssen M (1990) The pedicted and observed decline in onchocerciasis infection during the 14 years of successful control of Simulium spp. in West Africa. Bulletin of the World Health Organization 68, 331339.
  • 19
    Russel S, Fox-Rushby J, Arhin D (1995) Willingness and ability to pay for health care: a selection of methods and issues. Health Policy and Planning 10, 94101.
  • TDR (1996) African Onchocerciasis control: Patients to take over by 2008.
    TDR News no. 49, March 4–5.
  • 21
    Umeh RE, Chijioke CP, Okonkwo PO (1996) Eye disease in an Onchocerciasis endemic area of forest mosaic region of Nigeria. Bulletin of the World Health Organization 74, 95100.
  • Weaver A, Chapko M, Ndamobissi R
    et al. (1993) Estimating the willingness to pay for quality of care: comparison of contingent valuation and traditional economic methods. Health finance and sustainability project. University of Washington, Washington, pp. 8–17.
  • World Health Organization, (1987) WHO Expert Committee on Onchocerciasis. Third report.
    Technical Report Series 752, 5–25.
  • World Health Organization(1996)
    Community-directed treatment with ivermectin: Report of a multi-country study. World Health Organization, Geneva.
  • World Health Organization(1997)
    Prospects for elimination of some TDR diseases. TDRIGen/97, 1. World Health Organisation, Geneva.